# Copyright - Gravitate Health FHIR Implementation Guide (FHIR R4) v0.1.0

* [**Table of Contents**](toc.md)
* **Copyright**

## Copyright

This guide, as well the artifacts developped by HL7® including terminologies, is produced by HL7 under the terms of HL7® Governance and Operations Manual relating to Intellectual Property (Section 16), specifically its copyright, trademark and patent provisions.

This document is licensed under Creative Commons “No Rights Reserved” (CC0).

HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR ® are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.

This HL7 specification contains and references intellectual property owned by third parties (“Third Party IP”).

Implementers and testers of this specification SHALL abide by the license requirements for each terminology content artifact utilized within a functioning implementation. Terminology licenses SHALL be obtained from the Third Party IP owner for each code system and/or other specified artifact used. It is the sole responsibility of each organization deploying or testing this specification to ensure their implementations comply with licensing requirements of each Third Party IP.

Following is a non-exhaustive list of third-party terminologies used in this guide that may require a separate license:

| | | |
| :--- | :--- | :--- |
| EDQM Standard Terms | European Directorate for the Quality of Medicines (EDQM) | https://www.edqm.eu/en/standard-terms-database |
| ISO 3166 Country Code | International Organization for Standardization (ISO) | https://www.iso.org/iso-3166-country-codes.html |
| ISO 639-1 Language Code | International Organization for Standardization (ISO) | https://www.iso.org/iso-639-language-codes.html |
| Unified Codes for Units of Measures (UCUM) | Regenstrief Institute, Inc. and the UCUM Organization | http://unitsofmeasure.org/trac/wiki/TermsOfUse |

Refer to [IPS Implementation Guide](http://build.fhir.org/ig/HL7/fhir-ips/copyrights.html), Copyrights for further details.

